Soleus Private Equity Fund I L.P. 13D and 13G filings for BioAtla, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-02 4:30 pm Sale |
2024-10-01 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 1,237,909 2.560% |
-1,410,563 (-53.26%) |
Filing |
| 2024-09-06 4:59 pm Sale |
2024-08-19 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,648,472 5.500% |
-1,252,842 (-32.11%) |
Filing |
| 2024-04-16 09:15 am Sale |
2024-04-05 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,901,314 8.100% |
-319,083 (-7.56%) |
Filing |
| 2023-01-09 5:00 pm Purchase |
2022-06-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 4,220,397 9.200% |
1,972,873 (+87.78%) |
Filing |
| 2021-09-03 5:16 pm Sale |
2021-08-24 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,247,524 6.950% |
-546,709 (-19.57%) |
Filing |
| 2021-06-28 4:32 pm Sale |
2021-06-17 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 2,794,233 8.690% |
-400,000 (-12.52%) |
Filing |
| 2020-12-28 4:30 pm Purchase |
2020-12-15 | 13D | BioAtla, Inc. BCAB |
Soleus Private Equity Fund I L.P. | 3,194,233 9.930% |
3,194,233 (New Position) |
Filing |